As the earnings grow, IT may continue to be a slight outperformer. Pharma is pretty much now in line with where the market, says Anand Tandon.from Markets-Economic Times https://ift.tt/2G0xWvp
via
As the earnings grow, IT may continue to be a slight outperformer. Pharma is pretty much now in line with where the market, says Anand Tandon.from Markets-Economic Times https://ift.tt/2G0xWvp
via
No comments:
Post a Comment